Hood River Capital Management’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$52.1M	Sell	1,569,171 -12,063	-0.8%	-$359K	0.52%	66
2025 Q4	$47.1M	Buy	1,581,234 +28,446	+2%	+$929K	0.52%	67
2025 Q3	$56.1M	Sell	1,552,788 -14,718	-0.9%	-$485K	0.66%	56
2025 Q2	$56.4M	Buy	1,567,506 +11,018	+0.7%	+$410K	0.79%	46
2025 Q1	$61.4M	Buy	1,556,488 +101,165	+7%	+$3.4M	1.05%	38
2024 Q4	$43.8M	Sell	1,455,323 -175,026	-11%	-$5.02M	0.65%	63
2024 Q3	$38.1M	Buy	1,630,349 +57,420	+4%	+$1.25M	0.62%	63
2024 Q2	$28M	Buy	1,572,929 +98,892	+7%	+$1.58M	0.58%	64
2024 Q1	$22.4M	Buy	+1,474,037	New	+$23.5M	0.5%	69
2023 Q2	–	Sell	-739,112	Closed	-$11.1M	–	145
2023 Q1	$11.1M	Buy	+739,112	New	+$11.2M	0.36%	72
2022 Q1	–	Sell	-963,762	Closed	-$18.3M	–	160
2021 Q4	$18.3M	Buy	963,762 +609,756	+172%	+$15.8M	0.55%	64
2021 Q3	$11.8M	Sell	354,006 -13,498	-4%	-$418K	0.36%	77
2021 Q2	$14.3M	Sell	367,504 -5,234	-1%	-$206K	0.42%	78
2021 Q1	$18M	Buy	+372,738	New	+$17.9M	0.58%	69